Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Get the pump going before the Friday selloff

<< Previous

Bullboard Posts

Next >>

Comment by YanTheDonon Jun 21, 2018 3:22pm

79 Views

Post# 28208015

RE:Get the pump going before the Friday selloff

cohiba wrote: Ya think Rocket was placing the fake bids? Newbies getting sucked into a very early stage bio with very little cash. This will not end well.

I usually don't ignore ppl, but you're a lil annoying pest of a rat. You're done.

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 27, 2024